메뉴 건너뛰기




Volumn 4, Issue 1, 2012, Pages 11-17

Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis

Author keywords

Glycated albumin; Glycated hemoglobin; Hepatitis C virus; Liver biopsy; Liver fibrosis

Indexed keywords


EID: 84872089746     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v4.i1.11     Document Type: Article
Times cited : (20)

References (26)
  • 2
    • 0017835519 scopus 로고
    • The glycosylation of hemoglobin: relevance to diabetes mellitus
    • Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21-27
    • (1978) Science , vol.200 , pp. 21-27
    • Bunn, H.F.1    Gabbay, K.H.2    Gallop, P.M.3
  • 3
    • 0028988142 scopus 로고
    • Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level
    • Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995; 18: 440-447
    • (1995) Diabetes Care , vol.18 , pp. 440-447
    • Tahara, Y.1    Shima, K.2
  • 4
    • 0018742880 scopus 로고
    • Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients
    • Dolhofer R, Wieland OH. Glycosylation of serum albumin: elevated glycosyl-albumin in diabetic patients. FEBS Lett 1979; 103: 282-286
    • (1979) FEBS Lett , vol.103 , pp. 282-286
    • Dolhofer, R.1    Wieland, O.H.2
  • 6
    • 77957740531 scopus 로고    scopus 로고
    • Clinical impact of glycated albumin as another glycemic control marker
    • Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010; 57: 751-762
    • (2010) Endocr J , vol.57 , pp. 751-762
    • Koga, M.1    Kasayama, S.2
  • 7
    • 69749114550 scopus 로고    scopus 로고
    • Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease
    • Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009; 46: 368-372
    • (2009) Ann Clin Biochem , vol.46 , pp. 368-372
    • Bando, Y.1    Kanehara, H.2    Toya, D.3    Tanaka, N.4    Kasayama, S.5    Koga, M.6
  • 8
    • 47649129223 scopus 로고    scopus 로고
    • CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases
    • Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008; 81: 258-262
    • (2008) Diabetes Res Clin Pract , vol.81 , pp. 258-262
    • Koga, M.1    Kasayama, S.2    Kanehara, H.3    Bando, Y.4
  • 10
    • 0028234491 scopus 로고
    • Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C
    • The French METAVIR Cooperative Study Group
    • The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20
    • (1994) Hepatology , vol.20 , pp. 15-20
  • 11
    • 34548786091 scopus 로고    scopus 로고
    • Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review
    • Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46: 912-921
    • (2007) Hepatology , vol.46 , pp. 912-921
    • Shaheen, A.A.1    Myers, R.P.2
  • 14
    • 0345017740 scopus 로고    scopus 로고
    • Sampling variability of liver fibrosis in chronic hepatitis C
    • Bedossa P, Dargére D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
    • (2003) Hepatology , vol.38 , pp. 1449-1457
    • Bedossa, P.1    Dargére, D.2    Paradis, V.3
  • 16
    • 0035820265 scopus 로고    scopus 로고
    • Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study
    • Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075
    • (2001) Lancet , vol.357 , pp. 1069-1075
    • Imbert-Bismut, F.1    Ratziu, V.2    Pieroni, L.3    Charlotte, F.4    Benhamou, Y.5    Poynard, T.6
  • 20
    • 33847705375 scopus 로고    scopus 로고
    • FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C
    • Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007; 45: 297-306
    • (2007) Hepatology , vol.45 , pp. 297-306
    • Koda, M.1    Matunaga, Y.2    Kawakami, M.3    Kishimoto, Y.4    Suou, T.5    Murawaki, Y.6
  • 25
    • 79951473084 scopus 로고    scopus 로고
    • Acoustic Radiation Force Impulse (ARFI)--a new modality for the evaluation of liver fibrosis
    • Sporea I, Sirli R, Popescu A, Danilǎ M. Acoustic Radiation Force Impulse (ARFI)--a new modality for the evaluation of liver fibrosis. Med Ultrason 2010; 12: 26-31
    • (2010) Med Ultrason , vol.12 , pp. 26-31
    • Sporea, I.1    Sirli, R.2    Popescu, A.3    Danilǎ, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.